GB Patent

GB2097676A — Pharmaceutical composition for prevention of formation of N-nitroso compounds

Assigned to F Hoffmann La Roche AG · Expires 1982-11-10 · 44y expired

What this patent protects

Pharmaceutical preparations in the form of hydrodynamically balanced tablets or capsules, comprising a combination of an aqueous phase N-nitroso compound blocking agent and a lipid phase N-nitroso compound blocking agent. Preferably the blocking agents are respectively vitamin C …

USPTO Abstract

Pharmaceutical preparations in the form of hydrodynamically balanced tablets or capsules, comprising a combination of an aqueous phase N-nitroso compound blocking agent and a lipid phase N-nitroso compound blocking agent. Preferably the blocking agents are respectively vitamin C and vitamin E.

Drugs covered by this patent

Patent Metadata

Patent number
GB2097676A
Jurisdiction
GB
Classification
—
Expires
1982-11-10
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.